dc.contributor.author
Zhao, Jing
dc.contributor.author
Kader, Avan
dc.contributor.author
Mangarova, Dilyana B.
dc.contributor.author
Brangsch, Julia
dc.contributor.author
Brenner, Winfried
dc.contributor.author
Hamm, Bernd
dc.contributor.author
Makowski, Marcus R.
dc.date.accessioned
2021-09-02T13:58:25Z
dc.date.available
2021-09-02T13:58:25Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/31797
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-31529
dc.description.abstract
Simple Summary
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is an important method to analyze the perfusion model of tumors, allowing noninvasive quantification of microvascular structure and function. Furthermore, simultaneous [Ga-68]Ga-prostate-specific membrane antigen (PSMA)-11 positron emission tomography (PET)/MRI is currently the most advantageous way for assessing prostate cancer staging. Therefore, combining these two examinations helps to diagnose the lesions more comprehensively. Our study analyzes perfusion parameters between intraprostatic lesions and the correlation between perfusion parameters and [Ga-68]Ga-PSMA-11 PET. This study highlights the significant effect of PSMA uptake on perfusion parameters.
Abstract
We aimed to retrospectively compare the perfusion parameters measured from dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) of prostate benign lesions and malignant lesions to determine the relationship between perfusion parameters. DCE-MRI was performed in patients with PCa who underwent simultaneous [Ga-68]Ga-prostate-specific membrane antigen (PSMA)-11 positron emission tomography (PET)/MRI. Six perfusion parameters (arrival time (AT), time to peak (TTP), wash-in slope (W-in), wash-out slope (W-out), peak enhancement intensity (PEI), and initial area under the 60-s curve (iAUC)), and a semi-quantitative parameter, standardized uptake values maximum (SUVmax) were calculated by placing regions of interest in the largest area of the lesions. The DCE-MRI parameters between prostate benign and malignant lesions were compared. The DCE-MRI parameters in both the benign and malignant lesions subgroup with SUVmax <= 3.0 and SUVmax > 3.0 were compared. The correlation of DCE-MRI parameters was investigated. Malignant lesions demonstrated significantly shorter TTP and higher SUVmax than did benign lesions. In the benign and malignant lesions subgroup, perfusion parameters of lesions with SUVmax <= 3.0 show no significant difference to those with SUVmax > 3.0. DCE-MRI perfusion parameters show a close correlation with each other. DCE-MRI parameters reflect the perfusion characteristics of intraprostatic lesions with malignant lesions, demonstrating significantly shorter TTP. There is a moderate to strong correlation between DCE-MRI parameters. Semi-quantitative analysis reflects that malignant lesions show a significantly higher SUVmax than benign lesions.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
prostate cancer
en
dc.subject
dynamic contrast-enhanced
en
dc.subject
arrival time
en
dc.subject
time to peak
en
dc.subject
wash-in slope
en
dc.subject
wash-out slope
en
dc.subject
peak enhancement intensity
en
dc.subject
initial area under curve
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Dynamic Contrast-Enhanced MRI of Prostate Lesions of Simultaneous [68Ga]Ga-PSMA-11 PET/MRI: Comparison between Intraprostatic Lesions and Correlation between Perfusion Parameters
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1404
dcterms.bibliographicCitation.doi
10.3390/cancers13061404
dcterms.bibliographicCitation.journaltitle
Cancers
dcterms.bibliographicCitation.number
6
dcterms.bibliographicCitation.originalpublishername
MDPI AG
dcterms.bibliographicCitation.volume
13
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
33808685
dcterms.isPartOf.eissn
2072-6694